Cart
sales@molnova.com
Nodakenin
CAS No. 495-31-8
Nodakenin( —— )
Catalog No. M18650 CAS No. 495-31-8
Nodakenin is a compound with anti-allergic and anti-inflammatory activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 43 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 67 | In Stock |
|
| 25MG | 107 | In Stock |
|
| 50MG | 152 | In Stock |
|
| 100MG | 222 | In Stock |
|
| 200MG | 331 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNodakenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNodakenin is a compound with anti-allergic and anti-inflammatory activities.
-
DescriptionNodakenin is a compound with anti-allergic and anti-inflammatory activities.
-
In Vitro——
-
In VivoAnimal Model:Male ICR mice.Dosage:2.5, 5, 10 and 20 mg/kg.Administration:p.o, single dose.Result:Reversed in step-through latency induced by scopolamine.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorAChE
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number495-31-8
-
Formula Weight408.4
-
Molecular FormulaC20H24O9
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (244.86 mM)
-
SMILESc1(=O)ccc2cc3c(cc2o1)O[C@H](C3)C(C)(C)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Park SJ,et al. Effect of nodakenin on atopic dermatitis-like skin lesions. Biosci Biotechnol Biochem. 2014;78(9):1568-71.
molnova catalog
related products
-
4-IBP
4-IBP is a selective σ1 agonist with a high level of affinity for the σ1 receptor (Ki = 1.7 nM) and a moderate affinity for the σ2 receptor (Ki = 25.2 nM) .
-
Mitoridine
Mitoridine is an indole alkaloid compound isolated from the stem bark of Rauwolfia cumminsii Stapf.
-
Alisol B
Alisol B may be a potential novel therapeutic molecule for bone disorders through targeting the differentiation of osteoclasts as well as their functions.
